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RESEARCH ARTICLE
Site-1 protease regulates skeletal stem cell population and
osteogenic differentiation in mice
Debabrata Patra1,*, Elizabeth DeLassus2, Jennifer Mueller1, Grazia Abou-Ezzi3 and Linda J. Sandell1,4
ABSTRACT
Site-1 protease (S1P) is a proprotein convertase with essential
functions in the conversion of precursor proteins to their active form.
In earlier studies, we demonstrated that S1P ablation in the
chondrocyte lineage results in a drastic reduction in endochondral
bone formation. To investigate the mechanistic contribution of S1P to
bone development we ablated S1P in the osterix lineage in mice. S1P
ablation in this lineage results in osteochondrodysplasia and variable
degrees of early postnatal scoliosis. Embryonically, even though
Runx2 and osterix expression are normal, S1P ablation results in a
delay in vascular invasion and endochondral bone development.
Mice appear normal when born, but by day 7 display pronounced
dwarfism with fragile bones that exhibit significantly reduced mineral
density, mineral apposition rate, bone formation rate and reduced
osteoblasts indicating severe osteopenia. Mice suffer from a drastic
reduction in bone marrow mesenchymal progenitors as analyzed by
colony-forming unit-fibroblast assay. Fluorescence-activated cell sorting
analysis of the skeletal mesenchyme harvested from bone marrow and
collagenase-digested bone show a drastic reduction in hematopoietic
lineage-negative, endothelial-negative, CD105+ skeletal stem cells.
Bone marrow mesenchymal progenitors are unable to differentiate
into osteoblasts in vitro, with no effect on adipogenic differentiation.
Postnatal mice have smaller growth plates with reduced hypertrophic
zone. Thus, S1P controls bone development directly by regulating the
skeletal progenitor population and their differentiation into osteoblasts.
This article has an associated First Person interview with the first author
of the paper.
KEY WORDS: Site-1 protease, Skeletal stem cells, Osteopenia,
Osterix
INTRODUCTION
Site-1 protease (S1P), coded by theMbtps1 gene (membrane bound
transcription factor protease, site 1), is a proprotein convertase with
vital roles in lipid homeostasis and the unfolded protein response
(UPR) (Brown et al., 2000; Eberlé et al., 2004). These pathways are
fundamental to cellular homeostasis and involve the activation of
latent, endoplasmic reticulum (ER)-membrane-bound transcription
factors. Of late, newer roles have been attributed to S1P and the
transcription factors that it processes. OASIS (old astrocyte
specifically induced substance), a S1P substrate, is necessary for
type I collagen (Col1a1 and Col1a2) expression in mice, critical
for bone formation (Murakami et al., 2009). The processing of
N-acetylglucosamine-1-phosphotransferase α/β-subunit precursor
by S1P is essential to lysosome biogenesis, which impacts skeletal
development (Marschner et al., 2011). In the zebrafish gonzo
phenotype, S1P ablation results in both cartilage and lipid
phenotypes, but ablation of SCAP [the SREBP (sterol responsive
element binding protein) cleavage activating protein] results only in
lipid phenotypes (Schlombs et al., 2003). This indicates that not all
S1P functions are lipid regulated or mediated through transcription
factors, and is indicative of additional roles for S1P that impact
skeletal development.
We have demonstrated previously that S1P is essential to
skeletal development. S1P ablation in osteochondroprogenitors in
mice (S1Pcko; via Col2-Cre) results in chondrodysplasia (Patra
et al., 2014b, 2007). These mice show abnormal cartilage
development with type IIB procollagen (pro-Col IIB)
entrapment in the chondrocyte ER and a drastic reduction in
type II collagen (Col II) protein in the cartilage. The pro-Col IIB
entrapment is so drastic that it induces UPR and chondrocyte
apoptosis; these mice also lack endochondral bone. Postnatal
ablation of S1P in chondrocytes resulted in loss of hypertrophic
chondrocyte (HC) differentiation, elimination of the primary
growth plate and loss of bone growth (Patra et al., 2011). In these
studies, the cartilage phenotype was deemed a primary
consequence of the mutation and bone developmental defects a
consequence of cartilage defect.
To investigate if S1P has a direct role in bone development, we
ablated S1P in the osterix (Osx) lineage usingOsx-Cremice (Rodda
and McMahon, 2006). Osx is a transcription factor expressed in late
stages of endochondral ossification (Nishimura et al., 2012). It is
expressed strongly in osteoblast precursors and required for
osteoblast differentiation; it is also expressed in pre-HCs, where it
is required for maturation. Our observation that postnatal S1P
ablation obliterates HCs, coupled with the fact that HCs can
transdifferentiate into osteoblasts (Park et al., 2015; Yang et al.,
2014; Zhou et al., 2014), presented an opportunity to address the
importance of S1P to bone development via its ablation in the Osx
lineage. In this study, we show that S1P ablation in the Osx lineage
drastically downregulates postnatal bone development resulting in
osteopenia, indicating a direct role for S1P in bone development.
Our mechanistic characterizations show that S1P is necessary to
maintain the skeletal mesenchyme in the postnatal bone marrow. It
is also required for the differentiation of mesenchymal progenitors
into osteoblasts. Thus S1P is needed at multiple stages during bone
development.Received 29 December 2017; Accepted 22 January 2018
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RESULTS
S1P ablation in the Osx lineage results in dwarfism
To investigate roles for S1P in bone development, we used Osx-Cre
mice to ablate S1P in the Osx lineage. Homozygous S1P-ablation in
the Osx lineage (S1Pcko-Osx or Cko) results in dwarfism with very
fragile bones that often break easily from normal cage activities.
Heterozygously ablated S1P+/f-Osx (Het) mice are intermediate in
size to wild-type (WT) (S1Pf/f ) and S1Pcko-Osx mice and are smaller
than Osx-Cremice (Fig. 1A). S1Pcko-Osxmice often display varying
degrees of scoliosis that at times is severe (Fig. 1B; Fig. S1) and is
seen as early as 7-10 days postnatally (Fig. S1).
To investigate whether dwarfism is related to aberrant bone
development we analyzed the skeletons of these mice by micro-
computed tomography (μCT). Scanned images were developed by
OsiriX software and Jet color scheme to generate bone mineral
density (BMD) heat maps, in which yellowish-orange signifies
high, and blue low, values for BMD. Fig. 2A and Fig. S2 show that
bone development deviates very early and rapidly from normal,
postnatally. When compared to postnatal day (P) 1 mice (Fig. S2A),
P7 S1Pcko-Osx (Cko) mice are severely osteopenic with drastically
reduced BMD and smaller axial (Fig. 2A) and appendicular
(Fig. 2B) skeletal elements; S1P+/f-Osx (Het) mice are intermediate
to WT and S1Pcko-Osx mice (Fig. 2A,B). While no noticeable
differences in size and BMD are seen in P1 (Fig. S2A), reductions
in size and BMD are visible at P5 in S1P-ablated mice in
comparison toOsx-Cre or WTmice (Fig. S2B). In P7 Cko mice, the
mid-diaphyseal cortical bone is smaller in width with thinner
cortical bone when compared to WT mice (Fig. 2C); Het mice,
though showing no decrease in cortical bone thickness, are smaller
in width when compared to WT or Osx-Cre mice (Fig. 2C).
In dynamic histomorphometric analysis performed by calcein
(green)-alizarin (red) double labeling of bone, Cko mice exhibited a
significant reduction in both mineral apposition rate (MAR)
(Fig. 2E,F) and bone formation rate/bone surface (BFR/BS)
(Fig. 2G) that correlates well with the decrease in osteoblasts seen
on the endosteal surface of the cortical bone (Fig. 2D). However,
there was no change in osteoclast surface/bone surface (Oc.S/BS)
(Fig. S3A). These data indicate that S1P ablation induces osteopenia
very early postnatally, as seen by the significant decrease in bone
volume fraction (BV/TV) and volumetric BMD for the trabecular
(Fig. S3B,C) and cortical bone (Fig. S3D-F) in P7 mice, and a
drastic reduction in pMOI (a measure of resistance to torsional
force), confirming the fragile nature of the bone. To analyze how
these differences correlate with molecular changes in the bone, we
harvested RNA from the calvaria and long bones (femur/tibia) of
P10 and P21 mice, and analyzed for mature osteoblast markers by
quantitative real-time polymerase chain reaction (qPCR). Both
P10 (not shown) and P21 mice showed significant reductions in
type I procollagen ( proCol1a1), Bglap (osteocalcin) and alkaline
phosphatase (Alp) expression in the calvaria (Fig. S3G) and
primarily proCol1a1 in bone (Fig. S3H). These data indicate that
S1P ablation in the Osx lineage results in lower mature osteoblast
numbers in the postnatal bone, and is responsible for reduced bone
growth and dwarfism.
To verify that these phenotypes were caused by S1P ablation in
the Osx lineage in the developing skeleton, we performed in situ
hybridization (ISH) analysis forMbtps1-exon 2, the floxed allele in
S1Pf/f mice. Significant S1P ablation was observed in both pre-HCs
and HCs in both S1P+/f-Osx and S1Pcko-Osx mice, as seen by lack
of Mbtps1-exon 2 expression (Fig. S4A-J). Notably, as Cre is
Fig. 1. Mice with S1P ablation in the Osx lineage. (A) S1P ablation in the Osx lineage results in short-statured mice. Mice are 21 days postnatal (P21). (B)
Images from μCT scans of P21 mice showing severe scoliosis in S1Pcko-Osx. Scale bar: 2.5 mm.
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Fig. 2. Osteopenia due to S1Pablation in the Osx lineage. (A,B) BMD heat maps generated for P7Osx-Cre, WT (S1Pf/f ), S1P+/f-Osx (Het) and S1Pcko-Osx (Cko)
spines (A) and femora (B) from μCT scans processed by OsiriX using Jet color scheme (window location, 1440; window width, 1890; for all images). A typical
representation from several litters (N=3) is shown. (C) Mid-diaphyseal femoral cortical bone from μCT scans in P7 mice. (D) Gold-trichrome staining for
osteoblasts (reddish) lining the endosteal in P28 cortical bone, drastically reduced in the Cko. Arrow in Cko points to a lone osteoblast. (E) Calcein (green)-alizarin
(red) double-labeling of the endosteal surface of the femoral cortical bone in P28 mice (BM, bone marrow). (F) MAR (mean±s.d.; N=5). *P<0.0004
compared to WT/Osx-Cre; #P=0.006 (compared to Het). (G) BFR/BS (mean±s.d.; N=5). *P=0.0004 (compared to WT); #P=0.014 (compared to Het/Osx-Cre).
Scale bars: (A) 2.5 mm; (B) 1 mm; (C) 0.25 mm; (D,E) 25 μm.
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expressed as a GFP-fusion protein, GFP expression is observed in
pre-HCs/HCs that overlaps with zones of S1P ablation (compare
Fig. S4I,J with L,M); GFP is also seen in the perichondrium
(arrows, Fig. S4L,M). These data confirmed efficient S1P ablation
in zones of Osx expression, and that GFP expression in our mouse
model is a good surrogate for S1P ablation as reported earlier
(Rodda and McMahon, 2006).
S1P ablation in the Osx lineage delays endochondral bone
development
To investigate why S1P ablation in the Osx lineage results in
osteopenia, we first investigated embryonic bone development. At
embryonic day (E) 15.5, WT mice showed characteristic
development of the primary ossification center (POC) with
normal endochondral bone development (Fig. 3A). In S1P+/f-Osx
and S1Pcko-Osx mice, however, endochondral bone development is
delayed. In S1P+/f-Osxmice, only the beginning of vascular invasion
is seen at E15.5 (arrow, Fig. 3A); normal endochondral bone
development is observed later at E16.5. In S1Pcko-Osxmice, at E15.5
and E16.5 only cartilage is seen where normally the POC would
develop (brackets, Fig. 3A), with no evidence of vascular invasion;
endochondral bone development is seen later at E17.5. Even though
normal mineralization of the ECM is seen in all three genotypes
at E15.5 (Fig. 3B), immunofluorescence (IF) analysis for the
PECAM-1 antigen at E16.5 showed that vascular invasion is
delayed in S1Pcko-Osx (Fig. 3C).
To investigate this delay, we performed ISH analysis of several
molecular markers of the growth plate in E16.5 femora (Fig. 4). In
S1P-ablated mice, Ihh (in pre-HCs) andCol10a1 (in HCs) expression
is observed in the expected zones; the thickness of the zones and
expression levels of Ihh and Col10a1 are similar. Col1a1 expression
is seen in the cortical bone and endochondral bone (arrow, Fig. 4) in
the WT, but is primarily restricted to the cortical bones in mutant
mice. In S1P+/f-Osx mice, moderate Col1a1 expression is seen in the
POC, suggesting that endochondral bone development has begun but
is not as mature as in the WT. In S1Pcko-Osx mice, the presumptive
POC shows primarily chondrocyte-derived MMP13 expression with
faint tracings of vascular invasion by Col1a1-positive bone
progenitors. Consequently, MMP9 expression is seen only in the
cortical bone in S1Pcko-Osx, confirming its developmental lag.
S1Pcko-Osx mice display stronger VEGF expression than WT,
presumably upregulated to counter the delay in vascular invasion.
These data indicate that chondrocyte maturation during development
is not affected, despite the absence of S1P in the Osx lineage.
Morphological and ISH analysis performed in E16.5 Osx-Cre
(S1P+/+) control mice show robust endochondral bone
development similar to WT mice (Fig. S5), indicating that the
defects seen in S1P+/f-Osx and S1Pcko-Osxmice are due to S1P ablation.
Next, we analyzed the embryonic cartilage growth plate for Col II
protein. We performed double-labeled IF for Col IIA and Col II
triple helical domain (THD; the mature processed Col II in the
matrix) (Fig. S6) at E16.5. Our previous studies had demonstrated
that S1P ablation in the chondrocyte lineage resulted in intracellular
Col II entrapment with abnormal cartilage that impeded
endochondral bone development (Patra et al., 2014a, 2007).
However, S1P-ablation in the Osx lineage results in cartilage
matrix very similar to WT. In the resting (not shown) and
proliferating zones (zones where S1P is not ablated), the cartilage
matrix is identical in all three genotypes, with Col IIA (green) and
Col II THD (red) distributed identically (Fig. S6A-C) with no
intracellular Col II entrapment. As S1P ablation is restricted to the
pre-HCs/HCs, Col II entrapment is observed in these cells but only
in S1Pcko-Osx (arrows, Fig. S6F). In the WT and S1P+/f-Osxmice, Col
II THD (red) is seen primarily as clumps released from cells (arrows,
Fig. S6D,E). In the chondrocyte-derived MMP-13-expressing zone
present only in the S1Pcko-Osx growth plate, the matrix is made
primarily of Col IIA (green) with very little evidence of Col II
entrapment (Fig. S6G). Double-labeled IF for pro-Col IIB and Col
II THD demonstrated that the trapped collagen is pro-Col IIB, where
the signals from THD (red) overlap with signals from pro-Col IIB
(green) resulting in yellow colocalization signals (arrows, Fig. S6I).
However, this entrapment restricted to the hypertrophic zone does
not trigger apoptosis (not shown) or obliterate the growth plate.
Thus, Col II entrapment is not a defining feature of this mutant
phenotype, suggesting other mechanisms at play.
S1P ablation in the Osx lineage reduces osteoblast
development via a downregulation of mesenchymal
progenitors
Next, we studied the embryonic osteoblast lineage by analyzing for
Runx2 (Ducy et al., 1997; Komori et al., 1997; Otto et al., 1997) and
Osx (Nakashima et al., 2002), transcription factors that have vital
roles in osteoblastogenesis. Double-labeled IF for Runx2 (red) and
Col II THD (green) in E15.5 femora demonstrated that, like WT,
both S1P+/f-Osx and S1Pcko-Osxmice show normal Runx2 expression
in pre-HCs/HCs of the growth plate (Fig. 5A-C) and in the
perichondrium (Fig. 5D-F). Likewise, ISH analysis for Sp7 (Osx) in
E15.5 femora demonstrated normal Sp7 expression in all three
genotypes (Fig. 5G-I), though the expression pattern is different,
reflecting their developmental lag (Fig. 3A). Consequently, normal
type I collagen protein (Col I) deposition is seen in the bone collar of
S1P+/f-Osx and S1Pcko-Osx mice as in the WT (Fig. 5J-L). We also
investigated components of the Wnt/β-catenin signaling pathway
that have important roles in osteoblast differentiation (Hill et al.,
2005; Hu et al., 2005; Rodda and McMahon, 2006). Using protein
lysates made from the hind limbs of E14.5 mice, we investigated
phosphorylation levels of Akt and GSK-3β and total β-catenin
levels in immunoblots. Identical levels of Akt and GSK-3β
phosphorylation and β-catenin levels are observed in protein
lysates from all three genotypes (Fig. S7) indicating normal Wnt/
β-catenin signaling in mutant mice.
Next, we investigated if skeletal progenitors were affected. The
bone marrow is a niche for mesenchymal-derived skeletal stem cells
(SSCs) and recent studies have identified specific SSCs with
temporal and lineage-specific contributions to skeletal development
(Chan et al., 2015; Worthley et al., 2015). Besides, Osx is active in
bone marrow stromal cells (BMSCs) (Chen et al., 2014; Mizoguchi
et al., 2014), suggesting that S1P ablation in these cells could affect
the postnatal bone marrow compartment and, consequently, skeletal
development. Therefore, we first analyzed the ability of BMSCs
from P21 WT, S1P+/f-Osx (Het) and S1Pcko-Osx (Cko) mice to
form colony-forming unit-fibroblasts (CFU-F), a measure of
mesenchymal progenitors in the bone marrow. While the WT
and S1P+/f-Osx mice showed similar CFU-F capabilities, this
capability was significantly reduced in S1Pcko-Osx mice (Fig. 6A).
Next, we analyzed if the downregulation in CFU-F correlates with a
downregulation of SSCs. SSCs have been defined as CD105-
expressing (CD105+) cells that are triple negative for CD45,
Ter-119 and CD31 (Chan et al., 2015; Worthley et al., 2015). CD45
is expressed on most hematopoietic cells, except maturing erythroid
cells that express Ter-119; CD31 is expressed on endothelial cells.
Using fluorescent-conjugated antibodies for CD45, Ter-119, CD31
and CD105, we analyzed LIN− (CD45−, Ter-119−), CD31−,
CD105+ cells in the bone marrow/collagenase-digested bones from
4
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P21 mice by fluorescence-activated cell sorting (FACS) analysis. In
parallel to that seen for CFU-F, WT and S1P+/f-Osx mice showed
similar levels of LIN−, CD31−, CD105+ SSCs, while S1Pcko-Osx
mice demonstrated a drastic reduction in these SSCs (Fig. 6B-D).
Given the similar numbers of SSCs in WT and S1P+/f-Osx mice, it
was puzzling that S1P+/f-Osx mice are smaller than WT or Osx-Cre
mice. Therefore we analyzed the capacity of BMSCs for osteogenic
differentiation in vitro (Fig. 6E). WT mice showed strong
osteogenic differentiation in vitro as seen by the presence of
mineralized bone nodules. Control Osx-Cre (S1P+/+) mice also
demonstrated osteogenic differentiation (though this was reduced
when compared to WT). In contrast, neither S1P+/f-Osx or S1Pcko-Osx
Fig. 3. (A) Delayed endochondral ossification in S1P+/f-Osx and S1Pcko-Osxmice.Safranin O/Fast Green/Hematoxylin-stained femora fromWT, S1P+/f-Osx and
S1Pcko-Osx at embryonic time points. Arrow points to the beginnings of vascular invasion in S1P+/f-Osx at E15.5 but the absence of endochondral bone.
Brackets denote approximate boundaries of the central expanding zone of cells in S1Pcko-Osx in the absence of endochondral bone, at E15.5 and E16.5. (B) von
Kossa staining for mineralization of E15.5 femora. (C) IF for PECAM-1 at E16.5 (c, cartilage; b, bone). Arrow points to the beginning of vascular invasion in
S1Pcko-Osx. Scale bars: 100 μm.
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mice were able to demonstrate osteogenic differentiation. To
analyze if this was a generic progenitor issue, we analyzed if
BMSCs were capable of undergoing adipogenesis in vitro (Fig. 6E).
Interestingly, both S1P+/f-Osx and S1Pcko-Osx mice demonstrated
adipogenic differentiation similar to Osx-Cre and WT mice. These
data indicate a specific requirement for S1P not only to maintain the
SSC population but also for their osteogenic differentiation.
Interestingly, we found the presence of many GFP-expressing
(GFP+) cells in the bone marrow of S1Pcko-Osx (Cko) mice, which are
absent in WT or Het mice (Fig. 7), or age-matched Osx-Cre mice
(Fig. S8). Absence of GFP+ cells in the WT (which do not carry the
Osx-Cre transgene) is expected. But GFP+ cells are missing in the
bone marrow of S1P+/f-Osx (Het) (Fig. 7) or Osx-Cre mice (Fig. S8)
that carry the transgene, even though these mice show GFP+
chondrocytes in the hypertrophic zone of the growth plate (arrows,
Fig. S8). These GFP+ cells do not express osteocalcin (Ocn, a marker
of mature osteoblast), though Ocn was detected on bone surfaces
(arrow, Fig. 7D), and often appeared arranged in a rosette-like
structure in the bonemarrow (arrow, Fig. 7E). To study if the absence
of S1P induces apoptosis in bone marrow constituents, we analyzed
apoptosis by FACS using a fluorescent-labeledAnnexin V conjugate,
which detects apoptosis-induced externalization of
phosphatidylserine on the cell surface. However, no more apoptosis
was detected in the Cko bone marrow than that seen in WT or Het
(Fig. 7F). These GFP+ cells in the Cko bone marrow indicate that
these cells are in the Osx lineage and that their detection is possible
due to an arrest in differentiation, presumably to the osteoblast
lineage. The absence of these cells in the WT, Het and Osx-Cremice
indicates conditions favorable for SSCmaintenance andmaturation in
these mice. qPCR analysis of RNA harvested from the bone marrow
showed significant decrease in the expression of proCol1a1, Bglap,
Alp, Runx2 and also Col2a1 (a marker for osteochondroprogenitors)
in S1Pcko-Osxwhen compared toWTand S1P+/f-Osxmice (Fig. 7G), an
observation that parallels CFU-F and SSC levels seen in S1Pcko-Osx
mice. These data collectively indicate that S1P ablation in the Osx
lineage adversely affects bone development by downregulating
osteoprogenitors and their differentiation.
S1Pablation in theOsx lineage reduces the postnatal growth
plate
SSCs that contribute to the osteoblast lineage, downregulated in
S1Pcko-Osx mice, also contribute to the chondrocyte lineage (Chan
Fig. 4. ISH analyses of the growth plate in E16.5 femora for Ihh, Col10a1, MMP13, Col1a1 and MMP9, and in E15.5 femora for VEGF. Brackets denote
approximate boundaries of the central expanding zone of cells in S1Pcko-Osx (also see Fig. 3A). Scale bars: 250 μm.
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et al., 2015; Worthley et al., 2015). Therefore we investigated if
S1P ablation affects the postnatal cartilage and growth plate (Fig. 8).
The epiphyseal cartilage and growth plate in WT, S1P+/f-Osx and
S1Pcko-Osxmice look identical to each other up to 5 days postnatally.
The WT and S1P+/f-Osx mice showed identical phenotypes in this
analysis and therefore only WT and S1Pcko-Osx are shown. At P5,
with the exception of the bone width that is smaller in S1Pcko-Osx
mice, the growth plate and epiphyseal cartilage are indistinguishable
(Fig. 8A,B) (P5 S1Pcko-Osx mice are however smaller than WT,
Fig. S2B). The WT shows incipient secondary ossification center
(SOC) at P7 that develops further at P10 (arrows, Fig. 8C,E).
However, the SOC is completely absent even at P10 in S1Pcko-Osx
mice; it develops very slowly and even at P21 the epiphyseal
cartilage in the SOC is not completely replaced by trabecular bone
(Fig. S8C). The hypertrophic zone is smaller in S1Pcko-Osx (bracket,
Fig. 8F) when compared to WT (Fig. 8E).
To investigate if this was induced by abnormal Col II deposition,
we analyzed the epiphyseal cartilage by double-labeled IF for Col
IIA and Col II THD as above. No marked differences between WT
and S1Pcko-Osx mice is seen at any stage in Col II deposition (P5
shown as an example, Fig. 8G,H). However, S1Pcko-Osx showed
extensive chondrocyte apoptosis in the epiphyseal cartilage at P7
(arrow, Fig. 8J), just above the hypertrophic zone of the growth
plate. In previous studies, apoptosis was effected by abnormal pro-
Col IIB entrapment that induced UPR and delayed SOC formation
(Patra et al., 2011). However, no abnormal Col II entrapment was
observed at P5 (Fig. 8G,H) (or other stages, not shown).
Chondrocyte apoptosis overlapped with columnar cells of the
growth plate (which normally mature to HCs). ISH analysis showed
that while Col10a1 expression is observed in the presumptive SOC
(asterisk) and is uniform in the WT growth plate (Fig. 8K), it is
completely missing in the presumptive SOC (asterisk) in S1Pcko-Osx
and is patchy in the hypertrophic zone with large areas missing
Col10a1 expression (arrow, Fig. 8L). Apoptotic death of
chondrocytes would preclude their maturation to HCs that would
keep this zone small in S1Pcko-Osx. Recent studies demonstrated that
Gremlin1+ cells (Worthley et al., 2015) and CAR (Cxcl12-abundant
reticular) cells are a source of chondrocyte progenitors (Omatsu
et al., 2010). To investigate growth plate chondrocytes further in
light of the decline of the hypertrophic zone and non-uniform
expression of Col10a1, we analyzed Cxcl-12 and Gremlin1
expression in the P21 growth plate. Both WT and S1Pcko-Osx show
expression for Cxcl-12 and Gremlin1 in HCs, characteristically
missing in younger, proliferative chondrocytes (Fig. 8M-P). Similar
to Col10a1 expression, the WT has a bigger zone of Cxcl-12-
(Fig. 8M) and Gremlin1-expressing cells (Fig. 8O) than S1Pcko-Osx.
Like the hypertrophic zone (hz) in P7 mice (Fig. 8F,L), Cxcl-12-
(Fig. 8N) and Gremlin1-expressing (Fig. 8P) zones are greatly
reduced in S1Pcko-Osx. These observations confirm the significant
loss of postnatal growth plate chondrocytes and of the hypertrophic
zone in these mice. S1Pcko-Osx show a larger number of Cxcl-12- and
Gremlin1-expressing chondrocytes at the junction of the epiphyseal
bone with the growth plate (arrow, Fig. 8N,P) than the WT at this
junction. This expression is in chondrocytes left over from the
incompletely replaced epiphyseal cartilage in S1Pcko-Osx that is
otherwise efficiently replaced by bone in the WT (Fig. S8C).
DISCUSSION
S1P has emerged as a critical regulator of mammalian skeleton
development. It is a fundamental component of the regulated
intramembrane proteolysis system where it plays an active role
along with S2P (Mbtps2) protease in processing precursor proteins
Fig. 5. Molecular analysis of embryonic bone development. IF for Runx2 (red; A-F), Col II THD (green, A-C), and Col I (red, J-L) in E15.5 femora. D-F are
higher magnification images of A-C (magnified region outlined in A-C; shown without signals from Col II). ISH analysis for Sp7 (Osx) in E15.5 femora (G-I).
Scale bars: (A-C,J-L) 100 µm; (D-F) 10 µm; (G-I) 250 µm.
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to their active form (Brown and Goldstein, 1999; Eberlé et al.,
2004). Even though S1P mutations in humans are yet to be reported,
mutations in SREBP-2 (a major S1P/S2P substrate) are linked to
osteoarthritis pathogenesis in humans (Kostopoulou et al., 2012),
and mutations in S2P are linked to osteogenesis imperfecta (Lindert
et al., 2016). S1P therefore participates in a major homeostatic
pathway needed for skeletal development and maintenance. In this
study we demonstrated that S1P has a direct role in bone
development. Our studies on S1P in the Osx lineage have
identified a cellular mechanism where S1P is required to maintain
LIN−, CD31−, CD105+ SSCs of the skeletal mesenchyme, which
are precursors for chondrocyte and osteoblast lineages and for
osteoblast differentiation.
S1P ablation in the Osx lineage results in short-statured mice,
for which the extensiveness of their short stature correlates with
the degree of ablation, with the heterozygous S1P+/f-Osx showing
an intermediate size between the WT/Osx-Cre and S1Pcko-Osx.
S1Pcko-Osx mice suffer from osteochondrodysplasia as both
chondrocyte and osteoblast lineages are affected, contributing to
declining bone growth. Part of the reason could be due to a lack of
OASIS activity. OASIS, an established substrate for S1P, is a
transcription factor forCol1a1 andCol1a2 genes (Murakami et al.,
2009). However, while OASIS−/− mice are also smaller than WT,
this reduction in size is not as severe as seen in S1P-ablated mice.
Furthermore, qPCR analysis of RNA isolated from the calvaria of
OASIS−/− mice demonstrated a reduction only in Col1a1 and
Col1a2 expression, while Bglap and Alp were upregulated.
However, S1P-ablated mice show a drastic decrease in size that
can be discerned as early as P5 and a reduction in the expression of
proCol1a1, Bglap and Alp. Thus, unlike OASIS−/− mice, S1P
ablation in the Osx lineage mediates a global downregulation of
the osteoblast lineage, consistent with a role in maintaining SSC
population, and not via OASIS functions.
During embryonic bone development, at E13.5, before the
formation of bone marrow cavity, Osx+ progenitors from the
perichondrium migrate into the POC, along with blood vessels
(Maes et al., 2010; Mizoguchi et al., 2014). Because of the direct
association between vascular invasion and invading osteoprogenitors
that initiates POC development, a defect in either of these two
components could induce a delay in endochondral bone development.
Fig. 6. Downregulation of SSCs in S1Pcko-Osx. (A) Enumeration of CFU-F in P21WT, S1P+/f-Osx (Het) and S1Pcko-Osx (Cko) mice. Data shown as percent of WT
to normalize between biological repeats (mean±s.d.; *P<0.005 or not significant (ns) when compared to WT; N=3). (B,C) Scatter plot of FACS analysis for SSCs
from P21 WT (B) and S1Pcko-Osx (C). LIN−, CD31−, CD105+ cells are demarcated by an ellipse. A typical result is shown. (D) Enumeration of LIN−, CD31−,
CD105+ SSCs. Data shown as percent of WT (mean±s.d.; *P<0.001 or ns when compared to WT; N=4). (E) In vitro osteogenic and adipogenic differentiation
assays with BMSCs from P21 mice. Typical results are shown from N=3.
8
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A decrease or a defect in perichondrial osteoprogenitors is plausible
due to S1P ablation in these cells (due to Osx-Cre activity in
perichondrium deduced from the presence of GFP+ cells). A decrease/
defect in perichondrial osteoprogenitors could induce a delay, owing
to lack of adequate numbers of functional progenitors required to set
up the POC, or to crosstalk with the vascular invasion mechanism. A
delay in vascular invasion could be induced by the entrapped pro-Col
IIB in the hypertrophic zone in S1Pcko-Osx where vascular invasion
takes place. S1Pcko mice (Col2-Cre driven) suffered from a complete
lack of vascular invasion where pro-Col IIB entrapment was absolute
(Patra et al., 2014a, 2007). This suggests that clearing of the entrapped
pro-Col IIB in this zone by UPR may be necessary before vascular
invasion can begin. In contrast to S1Pcko mice, the limited pro-Coll B
entrapment in S1Pcko-Osx allows the removal of the trapped pro-Col llB
without inducing apoptosis. However, a delay in vascular invasion is
also seen in the heterozygous S1P+/f-Osx mice, which do not exhibit
any pro-Col IIB entrapment. Thus, S1P+/f-Osx mice may suffer from
only a lack of adequate Osx+ perichondrial progenitor functions, while
a defect in Osx+ perichondrial progenitors coupled to the entrapped
pro-Col IIBmay induce a more pronounced delay in vascular invasion
seen in S1Pcko-Osx mice.
Lineage tracing experiments have demonstrated the presence of
temporally distinct fetal, perinatal and adult Osx+ bone progenitors
(Maes et al., 2010; Mizoguchi et al., 2014). Fetal perichondrial
Osx+ progenitors contribute significantly to perinatal (∼8 day old
mice) bone and BMSCs, but not to adult bone or bone marrow.
However, perinatal Osx+ progenitors contribute to perinatal bone
development and to long-lived stromal cells that contribute to
Fig. 7. Analysis of the bonemarrow compartment. (A-C) GFP+ cells in the bonemarrow of P21 S1Pcko-Osx (Cko) femur, absent inWT or Het (also see Fig. S8).
Dashed lines show junction of bone marrow with cortical bone. (D) IF for osteocalcin (Ocn, red) in P21 Cko. (E) GFP+ rosettes (arrow) in the Cko bone
marrow (blue, DAPI-stained nuclei). (F) FACS analysis for apoptosis (% cells labeled with Annexin V conjugate) in cells from P21 bonemarrow (mean±s.d.;N=3).
(G) qPCR analysis forCol2a1, proCol1a1,Bglap,Alp andRunx2with RNA harvested from P21 bonemarrow (mean±s.d.;N=3; *P<0.05, #P<0.005, ##P<0.001, or
ns when compared to WT). Scale bars: (A-C) 100 µm; (D,E) 10 µm.
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osteolineages in growing and adult mice. This is in good standing
with our observations that the biggest differences in bone
development on S1P ablation in the Osx lineage is seen very
early perinatally, a consequence of S1P ablation in fetal Osx+
perichondrial progenitors. While the mice are similar in size when
born, P5 S1Pcko-Osx are easily detected due to their stunted growth,
which becomes more pronounced at P7. Postnatally, the presence of
GFP+ cells in the bone marrow of S1Pcko-Osx mice (missing in Osx-
Cre/WT/S1P+/f-Osx) and its size difference (much larger) from other
cells in the bone marrow indicate that they are not of hematopoietic
lineage, but a subpopulation of BMSCs. The expression of GFP
indicates that these are Osx+ osteoprogenitors arrested at a specific
stage of osteoblastogenesis that requires S1P. This rationale is
further supported by the inability of BMSCs to differentiate into
osteoblasts in vitro, coupled with an inability to detect osteoblasts/
bone lining cells in vivo. The similarity in the expression profile for
Col2a1, proCol1a1, Bglap and Alp between the WT and S1P+/f-Osx,
along with similar values for CFU-F and SSCs and the absence of
GFP+ cells indicate that their osteoblast differentiation program is
normal, which is in contrast to the homozygous knockout S1Pcko-Osx
mice. However, in vitro, S1P+/f-Osx differs from WT in its inability
to exhibit osteogenic differentiation, an aspect that presumably
contributes to its smaller skeletal size than the WT. S1Pcko-Osx mice
suffer from the double disadvantage that both bone (reduced CFU-F
and SSCs and defective osteogenic differentiation) and chondrocyte
(reduced growth plate thickness and hypertrophic zone) lineages are
downregulated. As HCs can transdifferentiate into osteoblasts, the
reduction of the hypertrophic zone in S1Pcko-Osx growth plate would
Fig. 8. Downregulation of the chondrocyte lineage in S1Pcko-Osxmice. (A-F) Safranin O-stained sections of the growth plate and epiphyseal cartilage in P5 (A,
B), P7 (C,D) and P10 (E,F) femora (distal end). Arrows in C and E point to the developing SOC. (G,H) Double-labeled IF for Col II THD (red) and Col IIA (green) in
P5 femora of WT (G) and S1Pcko-Osx (H). (I,J) TUNEL assay in P7WT and S1Pcko-Osx distal femora. Apoptosis (arrow) is seen in green against DAPI-stained blue
nuclei. (K,L) ISH analyses for Col10a1 in P7 femoral growth plate in WT (K) and S1Pcko-Osx (L). Asterisks mark the presumptive SOC. Arrow points to
regions of missing Col10a1 expression in S1Pcko-Osx hypertrophic zone. (M-P) IF for Cxcl-12 (red) (M,N) and Gremlin1 (red) (O,P) in P21 mice. Arrow points to
incomplete removal of cartilage from the epiphysis. (gp, growth plate; hz, hypertrophic zone; EB, epiphyseal bone; MB, metaphyseal bone). Scale bars:
(A-F,I-L) 250 μm; (G, H) 10 μm; (M-P) 100 μm.
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suggest a reduction in the number of HCs transdifferentiating to
osteoblasts and therefore a reduction of chondrocyte contribution to
osteoblast development. Thus, while there are different origins for
postnatal bone, the bone formed in S1Pcko-Osx mice has drastically
reduced contribution of Osx+ osteoprogenitors and, conceivably,
HCs-derived osteoblasts.
S1Pcko mice are unable to make any endochondral bone (Patra
et al., 2007). Though it did not prevent endochondral bone
formation, S1P ablation in the Osx lineage decreased overall bone
development drastically by downregulating SSC population and
preventing their differentiation. Thus, in S1Pcko, it is possible that
besides adversity from the abnormal cartilage, a defect in
osteoprogenitors also contributed to the lack of endochondral
bone formation. As most osteoblasts, CAR and CFU-F cells are
descendants of Col2-Cre+ cells (Ono et al., 2014); S1P ablation by
Col2-Cre may induce a stronger mutant phenotype as it targets a
more diverse population of osteoprogenitors than Osx-Cre. As
progenitors are derived from stem cells and Col2a1 is expressed in
bone marrow osteoprogenitors and not strictly in chondrocytes
(Szabova et al., 2009; Wang et al., 2011), the reduction in Col2a1
expression observed in the S1Pcko-Osx bone marrow presumably
reflects the observed reductions in CFU-F and SSCs in these mice.
These observations lend credence to the requirement of S1P in
maintaining the SSC population in the murine bone marrow. S1P
ablation in the Osx lineage, however, did not affect adipogenesis,
indicating that this ablation did not interfere with other progenitor
functions in the bone marrow. As S1P is not a secreted protein
(Pullikotil et al., 2007), this observation may suggest that S1P
ablation in the Osx lineage in the bone marrow does not cause non-
cell autonomous mutational effects, in agreement with mosaic
analysis in zebrafish (Schlombs et al., 2003). How S1P maintains
the SSC population is not known as we have not yet identified a
molecular target, but our studies clearly indicate a requirement for
S1P in the Osx lineage for normal bone development.
The development of scoliosis in S1Pcko-Osx mice very early
postnatally is reminiscent of adolescent idiopathic scoliosis (AIS) in
humans (Lonstein, 1994). The etiology of scoliosis remains unknown
although genetic predisposing factors likely contribute to this
multifactorial disease. Scoliosis may arise in S1Pcko-Osx due to the
reduction in BMD and consequent weak bones that cannot resist spine
bending and/or twisting. Poor bone quality as an etiological factor in
scoliosis remains controversial, but low BMD is a generalized
phenomenon and a systematic disorder in AIS. The prevalence of
AIS with osteoporosis is approximately 20-38% (Li et al., 2008). The
associated osteochondrodysplasia and low BMD seen in S1Pcko-Osx
mice suggests that it mimics the chondrodysplasia-related scoliosis
seen in humans (Mason et al., 2002). Studies show that scoliosis can
manifest due to gene deletions in osteochondroprogenitors; for
example, the Col2Cre-directed deletion of Neurofibromatosis type I
gene (Wang et al., 2011) or Src homology-2 gene (Kim et al., 2013).
Thus, S1P-ablated mouse models are uniquely placed to investigate
the molecular mechanisms for skeletal dysplasias and associated
spine abnormalities and provide a genetic starting point to study and




All mouse procedures were performed in accordance with the National
Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals,
using vertebrate animals/ethics protocols reviewed and approved by the
Animal Studies Committee at Washington University School of Medicine.
S1P ablation in the osterix lineage in mice
For mice with S1P ablation in the osterix (Osx) lineage, S1Pf/f mice (mice
homozygous for the floxed exon 2 ofMbtps1; in C57BL/6) (Yang et al., 2001)
were bred with Osx1-GFP::Cre [Cre recombinase expressed as a fusion
protein withGFP from the Sp7 (Osx) promoter] (Rodda andMcMahon, 2006)
transgenicmice in the C57BL/6J strain to produce S1P+/f;Osx-Cremice (mice
heterozygous for S1Pflox allele with Osx-Cre transgene). The heterozygous
S1P+/f;Osx-Cre (S1P+/f-Osx or Het) mice were bred with S1Pf/f mice to
generatemicewith homozygous deletion of S1P (S1Pf/f;Osx-Cre or S1Pcko-Osx
or Cko) in the Osx lineage. The Osx1-GFP::Cre (henceforth referred to as
Osx-Cre) mice can be regulated by the tetracycline transactivator (tTA) that
renders the Osx promoter inactive in the presence of doxycycline. In our
studies, the mice were never fed doxycycline and therefore the Osx-Cre
transgene was never temporally regulated by doxycycline. Genotypes were
verified by PCR analysis of tail-derived DNA. AsOsx-Cremice have skeletal
defects (Huang and Olsen, 2015), they were used as controls initially to
confirm that the mutant phenotypes were caused by S1P ablation; otherwise,
the heterozygote mice positive for Osx-Cre served as appropriate controls.
Males and females showed identical phenotypes. However S1Pcko-Osx mice
have difficulty surviving beyond weaning and require special and accessible
food supplies to prolong their survival further for a short time (typically
7-8 days) post-weaning.
μCT
For μCT analyses, mice were skinned, eviscerated, and fixed in 10% neutral
buffered formalin for 24-48 h, washed and stored in 70% ethanol. Skeletal
elements were scanned in a VivaCT 40 scanner (Scanco Medical AG,
Bruttisellen, Switzerland) at medium to high resolution and tube settings of
55 kV peak of energy, 145 μA of current with an integration time of 300 ms.
Segmentation was performed to distinguish high density (bone) from low
density (soft tissue/cartilage/growth plate) areas. Images from individual
scan slices or reconstructed bones were captured as TIFF images.
Morphometric measurements were calculated using 35-50 scan slices and
the manufacturer’s 3D analysis tools, and is based on the direct method of
calculation (Hildebrand et al., 1999). Bone mineral density (BMD) heat
maps were generated using OsiriX (Pixmeo SARL, Geneva, Switzerland)
software and Jet color scheme, where yellowish-orange represents highest
BMD and blue the lowest.
Dynamic histomorphometry
P21 mice were injected intraperitoneally with the fluorochrome calcein
green (Sigma-Aldrich; 10 mg/kg) followed by alizarin complexone
(Sigma-Aldrich; 30 mg/kg) 5 days later. Following alizarin administration,
the hind limbs were harvested 2 days later and embedded in methyl
methacrylate (Baron et al., 1983). Sections (10 μm thick) were visualized by
fluorescent microscopy for calcein/alizarin incorporation. In these young
mice, calcein-alizarin double labeling was observed primarily in the cortical
bones. Dynamic histomorphometric measures such as mineral apposition
rate (MAR), bone formation rate/bone surface (BFR/BS) and osteoclast
surface/bone surface (Oc.S/BS) for the endosteal surface of the cortical bone
was analyzed using Osteo II (BIOQUANT, Nashville, TN, USA).
qPCR analysis
For qPCR analysis, femur and tibia from hind limbs or calvariae were
harvested, muscle and other tissues removed, and the bone marrow flushed
out and analyzed separately. Bones and calvariae were pulverized in a
Mikro-Dismembrator U (B. Braun Biotech International Melsungen,
Germany) and RNA harvested using Trizol according to the
manufacturer’s recommended protocol and column purified by RNeasy
mini kit (Qiagen). RNA (1 μg) was reverse transcribed into cDNA using a
RT2 First Strand kit (Qiagen) and the cDNA used for qPCR analysis using
SYBR Green primer sets, 2X SYBRGreen mix (Life Technologies/Applied
Biosystems) using standard protocols and the relative amount of mRNA
calculated using the comparative CT method. As recommended by the
MIQE standards for qPCR, normalization was performed using both murine
Gapdh and 18S genes. Both control genes yielded identical results. SYBR
Green primer sets for the murine 18S (Yoda et al., 2010),Gapdh, proCol1a1
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(type I procollagen, alpha1), Bglap (osteocalcin) and alkaline phosphatase
(Alp) are as previously reported (Zhang et al., 2011).
CFU-F assay
For CFU-F assays, the bone marrow was harvested from both hind limbs of
P21 mice and red blood cells (RBCs) lysed using RBC lysis buffer (Sigma-
Aldrich). Nucleated cells (1×106) were then plated in T75 cm2 flasks and
cultured for 2 days in α-MEM with 20% fetal bovine serum (FBS) and 2%
penicillin/streptomycin. After 2 days, the medium was removed completely
to remove dead cells, fresh medium added and cultured for a further 8 days,
at which point colonies were stained with Methylene Blue. Only colonies
that had at least 50 cells were counted as a viable colony.
FACS analysis for CD105+ SSCs
Analysis of LIN-negative (CD45−, Ter-119−), endothelial-negative (CD31−),
CD105+ SSCs were done as described (Worthley et al., 2015). Briefly, long
bones (striped of skin andmuscle tissue) from the hind limbs of P21micewere
harvested, crushed in a mortar and pestle with PBS and filtered using a 50 μm
filter. The sediment in the filter was digestedwith collagenase type IV (1.7 mg/
ml) (Thermo Fisher Scientific) for 10 min at 37°C andmixed with filtrate from
above. After several washings in PBS (with 0.1% bovine serum albumin), the
cells were incubated with fluorescent-conjugated antibodies to CD45 (PE-
Cy7) (552848, BD Pharmingen, San Jose, CA, USA), Ter-119 (PE-Cy7) (25-
5921, eBioscience, San Diego, CA, USA), CD31 (BV421) (BD Pharmingen,
563356), and CD105 (Alexa Fluor 647) (562761, BD Pharmingen) and FACS
analysis performed on BD FACSAria following standard protocols. In gating
analysis (performed by FlowJo_V10; www.flowjo.com), single cells were
gated negatively for PE-Cy7 signals (CD45- and Ter-119-expressing) to
remove hematopoietic and erythrocyte cells, followed by negative gating for
BV421 signals (CD31-expressing) to remove endothelial cells from the
population of CD105+ cells (Alexa Fluor 647 signals).
In vitro osteogenic and adipogenic differentiation assays
Bone marrow was harvested from the hind limbs of P21 mice and the
resulting cell population obtained after lysis of RBCs were cultured in a
single well of a six-well plate in α-MEM with 20% FBS and 2% penicillin/
streptomycin until confluent. Once confluent, cells were passaged into a
6 cm dish and cultured until confluent. The cells were then cultured in two
wells of a six-well plate, grown until confluent at which point osteogenic
differentiation media (α-MEM with 10% FBS, 2% penicillin/
streptomycin,10 mM β-glycerophosphate, 50 μg/ml of ascorbic acid) was
added and cultured for 14 days. Osteogenic differentiation was assessed by
silver staining of the mineralized matrix by the von Kossa method. For
adipogenic differentiation, cells obtained after lysis of RBCs were cultured
in a single well of a six-well plate in complete MesenCult™ Expansion
medium (STEMCELL Technologies, Vancouver, Canada) at 37°C under
hypoxic conditions until 80-90% confluent. The medium was then replaced
with complete MesenCult™ Adipogenic Medium (STEMCELL
Technologies), and the cells were incubated further at 37°C in hypoxic
conditions with a change in medium every 3 days for a total of 14 days.
Adipogenic differentiation was analyzed by staining for lipid droplets by Oil
Red O.
ISH analysis
ISH analyses were performed on 5-µm paraffin-embedded sections as
described previously using 35S-labeled riboprobes (Long et al., 2001; Patra
et al., 2007). ISH images were viewed with a BX51 microscope (Olympus,
Waltham, MA, USA) and images captured with a digital camera (DP70;
Olympus) using DP controller software (Olympus). Images of hybridization
signals were pseudo-colored red and superimposed on Toluidine Blue-
counterstained images using Photoshop (Adobe).
Antibodies, immunofluorescence, and imaging
Western blot analysis for Akt (9272, Cell Signaling Technology), phospho-
Akt (9271, Cell Signaling Technology), GSK-3β (9315, Cell Signaling
Technology), phospho-GSK-3β (9323, Cell Signaling Technology), and
β-catenin (sc-7199, Santa Cruz Biotechnology) proteins in protein lysates
from E14.5 hind limbs were performed as described (Duan et al., 2015).
Antibodies to the type II collagen (Col II) triple helical domain (THD), type
IIA procollagen (Col IIA) and the type IIB procollagen (pro-Col IIB) and
their use in double-labeled IF to analyze the cartilage matrix are as reported
(Patra et al., 2014a, 2007). IF for PECAM-1, Runx2, type I collagen (Col I),
osteocalcin, Cxcl-12 and Gremlin1 proteins was performed on frozen hind
limb sections after fixing tissues overnight with 4% formaldehyde (Duan
et al., 2015). Antibody concentrations were as follows: antibodies to
PECAM-1 (BDBiosciences), osteocalcin (ab93876, Abcam), Gremlin1 (sc-
18274, Santa Cruz Biotechnology) and Cxcl-12 (ab18919, Abcam) were
used at 1:50; antibodies to Runx2 (ab23981, Abcam) and Col 1 (ab21286,
Abcam) were used at 1:250 and 1:100, respectively. Secondary antibodies
(Life Technologies) were Alexa Fluor 594-conjugated donkey anti-rabbit
(A-21207) or anti-rat (A-21209), used at 1:250. Signal amplification using a
TSA kit (Thermo Fisher Scientific) was used for osteocalcin and Gremlin1
antibodies only. All antibodies were tested and validated for specific
staining and showed negligible background staining. Images were captured
using a 60×, 1.4 NA oil immersion objective mounted on an Eclipse E800
microscope (Nikon, Melville, NY, USA) and QImaging Retiga 2000R Fast
1394 camera and deconvolved. For deconvolution imaging, MetaMorph
software (Molecular Devices) was used to control the Z-motor device (Prior
Scientific, Cambridge, UK), and also to capture, deconvolve images and
compile them to give a final image.
Apoptosis assays
Detection of apoptosis on formalin-fixed tissues was performed by TUNEL
assay using the in situ cell death detection kit (Roche) according to the
manufacturer’s instructions. Analysis of apoptosis in the mouse bone
marrow (with or without lysis of red blood cells) was performed by labeling
bone marrow cells harvested from P21 hind limbs with Andy Fluor
647-Annexin V conjugate (GeneCopoeia, Rockville, MD, USA) to detect
the presence of external phosphatidylserines on the surface of cells induced
by apoptosis, following the manufacturer’s recommended protocol.
Detection of fluorescent signals was performed on BD LSR II followed
by analysis using FlowJo_V10.
Statistical analysis
Statistical data are reported as mean±s.d. A two-tailed Student’s t-test was
used to compute values.P<0.05 is considered statistically significant. Number
of mice per genotype (N) in each data set is reported in figure legends.
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